Saba Capital sells $131,193 in BlackRock ECAT common stock
Saba Capital sold 9,252 shares of BlackRock ESG Capital Allocation Term Trust (ECAT) for $131,193. The sale price was $14.18 per share, slightly above the current $14.14. ECAT has a 22.52% dividend yield and a 7.68% YTD return. Saba still holds 12,522,047 shares, maintaining a significant position in the $1.4B market cap trust.
How this was made
The 30-second read
Why it matters
The disclosed sale provides fresh data on ownership changes for ECAT, but the small size limits market impact.
Market read
Provides a new insider sale detail for ECAT; limited trading relevance due to small transaction size.
What to watch
Saba Capital still holds over 12.5 million shares, indicating continued confidence in the trust.
Background
The article reports an insider transaction by Saba Capital, a known 10% owner of ECAT, disclosing a modest share sale.
Ticker impact
Saba Capital sold 9,252 shares of BlackRock ESG Capital Allocation Term Trust (ECAT) for $131,193, reducing its stake.
likely modest pressure as the market prices in the insider sell
The sale size is small relative to the fund's market cap, but the price was above the current level, suggesting a short‑term sell signal.
Market effects
Minimal impact on the broader ESG ETF sector; the trade reflects a routine portfolio adjustment.
No significant regional effect; the transaction is confined to a US‑listed trust.
Limited global relevance; only investors tracking ECAT may note the sale.
Counterpoint
The sale could be interpreted as a strategic reallocation rather than a negative signal for ECAT.
Key entities
- InvestorSaba Capital Management, L.P.
10% owner of ECAT that sold 9,252 shares.
- ETF TrustBlackRock ESG Capital Allocation Term Trust
Ticker ECAT, the subject of the insider sale.
